ACM Research builds machines that clean and coat chip wafers
Cleaning machines
wash silicon wafers between the steps of making a chip
Plating and furnaces
coat and heat wafers
Mainland China
where nearly all its sales go
A chip is built in hundreds of steps, and the wafer must be washed spotless between many of them. ACM's machines clean one wafer at a time, replacing tools that dip whole batches.
The company · 2 · What exactly does it sell?
Cleaning machines are seven tenths of sales
Each $1 of sales, 2025
70%22%8%
Cleaning machinesPlating, furnaces and newer toolsPackaging tools, service and spares
Chip factories buy each machine once, then order more of the same model as they expand. ACM's main operations are in China, run by a Chinese subsidiary that is separately listed.
The company · 3 · How does it make money?
It keeps about 15 cents of each sales dollar
15.1 centsprofit per sales dollar last quarter, from 10.7
52%of 2025 sales from four customers
6 of 7recent quarters used more cash than came in
Research, selling and offices take the same share of each dollar as when ACM was a third its size, so growth has not added profit per dollar. Stock and unpaid bills keep piling up.
Is it a good business? · 4 · What gives it an edge?
Once a machine passes, the next order goes to it
1,255 repeats
of the 1,435-plus machines shipped since 2009
2,000th
plating chamber this year, from 500 in 2022
A chip factory spends months approving a machine, and a rival's would have to pass every test again, so the approved supplier gets the repeat orders. Lam Research credits its own installed machines with the same pull.
Is it a good business? · 5 · What is the catch?
A Chinese rival sells the same machines, and the US restricts it
NAURAsells cleaning, plating and furnaces to the same factories
Entity Listits two operating arms are on this US trade list
Being on the US list means ACM cannot receive controlled American technology without a licence. ACM's own report warns that more local rivals are coming.
Is it a good business? · 6 · What does its record show?
Sales tripled in four years; profit per dollar did not rise
Sales, $B
0.3
0.4
0.6
0.8
0.9
1.1
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales, latest quarter+36.6%to $367.7M
Cleaning machines+16%after shrinking 14% in June
Cash in hand$1.28Bdown from $1.36B
Growth is real, but reported profit swings with paper gains on investments, and the cash statement tells a weaker story than the headline.
Is it a good business? · 7 · How much room is there to grow?
A large market, in the one country set to shrink
$39.3Bchip equipment bought in China in 2025
$35.4Bforecast for 2026, a 9.9% fall
$7.3Bwhat ACM reckons its cleaning machines can bid for
ACM sold $901.3M last year, so there is room to grow, but its home market is forecast to shrink.
Is it a good business? · 8 · Who is in charge?
The founder controls the vote
Since 1998David Wang, founder and chief executive
20 votesper share of his class, most of the vote
His brother runs the Chinese subsidiary. Bonuses follow no formula: the board decides. Long-term pay is stock options, which pay only if the share price rises. Insiders made 69 sales and no purchases over the last year.
The story right now · 9 · Why is China buying local machines?
China is pushing its chip factories to buy home-grown tools
US limitson selling advanced chip machines to China
ACM, NAURAthe home-grown suppliers Chinese factories favour
-9.9%China's equipment spending forecast for 2026
American export rules limit what Chinese chipmakers can buy from abroad, so they turn to local suppliers like ACM and NAURA. That helps ACM win orders, but ties it to one country's spending.
The story right now · 10 · Why watch the cash, not profit?
A sale counts as profit before the customer pays
A machine shipsThe sale and profit are recorded.
The customer pays laterOften many months later.
Unpaid bills pile upAnd stock waiting to ship.
Cash goes out, not inFive of six recent quarters.
Profit can look healthy while the business uses cash. If customers keep paying slowly, ACM must fund the gap from its cash pile, which has started to shrink.
The story right now · 11 · What changed lately?
Sales rose 37% and cleaning grew again
+36.6%third-quarter sales
3 raisesof this year's sales forecast
PECVD, Trackno first order yet for either new machine type
-$70.4Mcash from running the business in the third quarter
Solid quarter
The rebound in cleaning we waited for came. The first order for a newest machine type, and cash coming in rather than out, are still missing.
The story right now · 12 · What is everyone arguing about?
Can ACM grow beyond cleaning, and turn profit into cash?
Many investors think
A Chinese equipment winner worth buying on the dip
We think
Real growth, but in unproven machines and a shrinking market
If the new machine types win orders and cash turns positive, we were too cautious. Until then, the price sits only a little under our estimate, short of the cushion these risks call for.
The price and our view · 13 · What is a share worth?
The price sits about an eighth below our value
$50.85what we think a share is worth · the last close is of that
$50.85our value
Attractive below $40.68
Neutral
Unattractive above $61.02
$23.06gloomy: growth halves and profit per sale slips
$50.85our estimate: experts' fast forecasts, then slowing
$75.19sunny: growth runs a quarter faster
Value per share in three futures. None is a prediction of the share price.
We estimate what a share is worth from the cash the business should earn over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.
The price and our view · 14 · What if it all works?
The new machine types could add a lot, at little cost
Asymmetricthe kind of bet this is
2.1×if it works
100%kept if it fails
Multiples of the company's value when the bet was last struck, 12 Nov 2026.
If its two newest machine types win production orders, the shares could be worth about twice as much. If they never sell, little is lost. That makes this bet lopsided in the buyer's favour.
The price and our view · 15 · How could we be wrong?
Blacklisted, concentrated and short of cash
Both arms blacklistedBiggest
No controlled US technology without a licence.
One shrinking countryWatch
Almost all sales go to mainland China.
Profit that is not cashShowing now
Operations used cash in most quarters.
A Hong Kong listingUnknown
It could shrink ACM's 72.8% stake.
A further American export rule could limit what the Chinese subsidiary can buy or ship, which would move our view down.
The price and our view · 16 · How will we know?
A first order for a new machine would change the view
A production order for one of its newest machinesGood sign
Cash from running the business turns positiveGood sign
A new US export rule hits the Chinese subsidiaryWe turn negative
FEB 202725
Results for the last quarter of 2026. Companies report every three months; each report is a test of the story.
Our view also changes on price alone: we turn positive if the shares fall a fifth below our estimate, and negative if they rise a fifth above it.
The price and our view · 17 · So, what do we think?
Cheap against rivals, but the risks earn the discount
$50.85our value
Attractive below $40.68
Neutral
Unattractive above $61.02
NeutralMedium conviction
ACM's machines win repeat orders and sales are growing fast. But it sells almost only to China, sits on a US blacklist and its profit is not turning into cash. The price is fair, not cheap.
↑ ↓ to move · C for contents
What it does
More about the company
Who it is
A chip is built up in hundreds of steps, and between many of them the silicon wafer must be washed free of specks far too small to see. ACM Research makes machines that do that washing one wafer at a time, replacing older tools that dip whole batches into a bath.
Cleaning was about 70% of 2025 sales. The rest is copper-plating machines, furnaces, packaging equipment and two newer lines called PECVD and Track.
How it makes money
A chip factory first tests a tool on its own line, then buys it outright, and spare parts and service follow. The next sale comes when that factory adds capacity, or a sister factory copies a line that already works.
Growth and profit
What growth costs
Growing has not made ACM Research cheaper to run. Its spending on research, selling and administration has stayed about the same share of every sales dollar while sales more than tripled, and management plans to keep it there. Profit margins have risen and fallen with the price it gets for its tools, not with its size.
Its record
The numbers
Is it growing?Fast
Sales grew 29% over the twelve months to Sep 2026, faster than the 15% in the year to Dec 2025.
Is it profitable?Healthy
Operating margin is 14%, down from 17% in the year to Dec 2023.
Does growth pay off?Flat
Running costs take 29¢ of each sales dollar, about where it was (29¢) in the year to Dec 2021.
Does it earn good returns?Low
Each dollar put into the business earns 7.2% a year after tax, about where it was (8.6%) in the year to Dec 2021.
How long can it keep going?Long runway
It used $199M of cash over the last twelve months, so the $952M it holds lasts about 4.8 years at that pace.
Is the balance sheet safe?Net cash
It holds $952M of cash against $343M of debt, $609M more cash than it owes.
Are shares being diluted?Creeping
The share count rose 13% in 4.8 years, and pay in shares costs 2.6% of sales.
Why it wins
The evidence
A chip factory spends months approving a tool against its own recipe. Once a tool passes, the next order goes to the same machine, because a rival's would have to pass all over again.
The trace is in the orders: more than 1,255 of the 1,435-plus tools shipped since 2009 were repeats, and the plating line went from its 500th chamber in 2022 to its 2,000th this year. Lam Research, the largest rival, credits its own installed base with the same pull in its annual report.
Who could beat it
The rivals in full
NAURA, a Chinese toolmaker, sells cleaning, plating and furnace machines to the same mainland factories, and ACM's own annual report warns of more local entrants. NAURA grew strongly in 2025 on China's push to buy home-grown tools, though a trade paper saw thinner margins ahead.
Each rival
NAURA Technology Group002371.SZ
Wafer cleaning, plating and furnace tool orders at mainland China fabs that might otherwise default to ACM given ACM's historical China concentration.
Lam Research, Applied Materials and Suzhou JingtuoLRCXAMAT
PECVD and Track tool orders that fabs already place with these incumbents, whose qualified tools ACM's evaluation units must displace before any production order.
How big it could get
The market and who has signed
The market
The world's chip factories will spend about $138.5B on equipment in 2026. ACM reckons its current machines can bid for $7.3B of cleaning, $5.3B of PECVD, $3.0B of Track, $2.6B of furnaces and $1.5B of plating. It sold $901.3M last year.
The catch is where. Mainland China's equipment spending is forecast to fall 9.9% in 2026, from $39.3B to $35.4B.
Who has signed
Very little. Last quarter brought the first disclosed orders for a tool that plates large square panels instead of round wafers: one production order and one trial machine, both from unnamed customers and neither with a value.
Who runs it
Leaders, pay and the cash
Who runs it
David Wang founded ACM Research in 1998 and still runs it; the same finance chief has served since 2019, and the CEO's brother runs the Chinese subsidiary. Through shares with twenty votes each, Wang alone controls most of the vote, so outside holders cannot outvote him. Bonuses have no formula: the board decides, citing sales growth and margins. Long-term pay is stock options, which pay only if the share price rises.
The last report
The latest report
ACM Research sales rose 37%, cleaning grew again, forecast raised
What it did to the thesis Solid quarter
The cleaning rebound we were waiting for came. The first order for the new tool lines and the cash from operations are still missing, so the view stays Neutral.
The report
The September quarter was strong. Sales rose 36.6% to $367.7M, the flagship cleaning line grew 16% after shrinking 14% in the June quarter, and the full-year forecast rose to $1.24B-$1.28B from $1.125B-$1.175B. Operating profit was 15.1% of sales against 10.7%.
Three things did not follow. Orders shipped grew 31%, slower than sales; the share of sales left after making the tools slipped to 41.5%; and cash fell to $1.28B from $1.36B. On the call, management said Track tools are in customer trials and shipments should rise in the fourth quarter, but named no first order for PECVD or Track.
What's happening now
The background
The company has raised its full-year forecast three times this year, most recently on 5 November, and says first-half orders more than doubled. The September-quarter release showed cleaning growing again; the first production order for PECVD or Track, both still on trial, was not in it or on the call.
The quarterly filing, due in days, should say what cash from operations was. The next full report is expected on 25 February 2027.
Where we disagree
Both sides in full
The market
A Chinese equipment winner riding AI and the push for home-grown tools, worth buying on the dip: 8 of 10 analysts say buy.
We believe
The growth is real, but it sits in unproven tool lines and in the one market forecast to shrink.
The argument
The market sees three raised forecasts and earnings beats in 6 of the last 8 quarters. But the reported figure is flattered or hurt by paper gains and losses on investments, and the cash statement and the shrinking stake in the Chinese arm sit far from the headline.
If the new lines win production orders and cash turns positive, management's confidence was earned and we were too cautious. Cleaning growing again removes one of our doubts, not the others.
What it's worth
How we value it
Valued on the analysts' revenue path for three years, each later year closing 30% of the gap to 4%, on official operating profit with stock pay a cost and tax paid in full; the thesis's own evidence is the check on that path. Less $572.3M of book equity held by ACM Shanghai's outside shareholders at 30 September 2026, since the sales and profit valued are the whole subsidiary's and ACM Research owns 72.8% of it.
What the price assumes
Sales growth in the first year, then slowing as ours does, at the same profit per sale.
The price assumed
20.1%
Our estimate
25%
Measured at the close of
16 Nov 2026
The three cases
Bear case$23.06
Growth runs at half the analysts' path, 12%, 13% and 9%, the margin settles a fifth lower at 12.9%, and new capital earns only the 8% rate: the downturn test.
Our value$50.85
Revenue grows 25%, 26% and 17% over three years, the analysts' path (C59), then fades toward 4%, closing 30% of the gap each year; the margin moves to 16.1%, the analysts' year-three figure after stock pay and on the filed basis (4.2% less).
Bull case$75.19
Growth runs a quarter above the analysts' path, 31%, 32% and 22%, the margin reaches 17.7%, and new capital earns 15%.
The bet
Seen as a bet
This bet is on one business only: PECVD and Track, two new kinds of chip-making tool that customers are still testing. Everything else ACM sells is counted separately, at the company's own price for its sales, and if it meets this year's guidance it covers today's price on its own.
So today's price asks nothing of the new tools. But even a first foothold in their market adds little to the company's value, which makes it an expensive bet; if neither tool ever wins an order, little is lost.
What could go wrong
Every risk
The risks
Both operating arms blacklisted
Since December 2024 nobody anywhere may supply ACM Shanghai or ACM Korea with controlled American technology without a US licence.
One country, forecast to shrink
Substantially all sales have gone to mainland China, where equipment spending is forecast to fall 9.9% in 2026.
A few big customers
Four customers were 52% of 2025 sales and 62% of what customers owed at the year end.
Profit that is not cash
Operations consumed cash in five of the last six quarters, as unsold inventory and unpaid customer bills piled up.
Insiders selling
Insiders made 69 open-market sales and no purchases over the last year.
What we still do not know
How far a planned Hong Kong listing of the Chinese subsidiary, now approved by its shareholders, would shrink ACM Research's 72.8% stake.
Whether swapping blacklisted American parts for local ones works, beyond the company saying so.
How much more outside money the Chinese arm will raise, and at whose expense.
What changes our view
Every route to a new view
Every route to a new view
→ Attractive
The share price falls to about $40.68, 80% of what we think the business is worth, so it is cheap enough.
→ Unattractive
The share price rises to about $61.02, 20% above what we think the business is worth.
→ Unattractive
A further American export restriction limits what the Chinese subsidiary can buy or ship. The Chinese subsidiary lists in Hong Kong, further shrinking ACM Research's share of its own operating business.
The next test
It supports the case if
A disclosed production order for PECVD or Track, positive operating cash flow, and Q4 revenue of at least $348M with cleaning revenue holding above $200M.
It pressures the case if
No PECVD or Track production order disclosed by the Q4 report, operating cash flow negative again, or Q4 revenue below $348M.
We would also be wrong if
Operations keep consuming cash for two more quarters despite the reported profit.
The verdict
Scores and how we weighed it
The scores
Growth
3 of 4
Business quality
3 of 4
Financial position
2 of 4
Execution record
3 of 4
Per share capture
2 of 4
Potential
3 of 4
Risk profile
2 of 4
Valuation
3 of 4
Evidence quality
3 of 4
How we weighed it
ValueMixed
The price is a little under our value once the outside owners of its Chinese arm are counted, inside the margin of safety.
BusinessMixed
Machines that clean and plate wafers, but profit has not turned into cash.
GrowthMixed
Growth depends on new tool lines winning production orders, none yet.
RisksNegative
Both operating arms are blacklisted, sales sit in one country forecast to shrink, and a few customers dominate.
RivalsPositive
Cheaper than both listed rivals its own filing names, on every measure.
The groupMixed
Chip-equipment names move together on spending news; its China exposure is its own.
Latest newsNegative
The cleaning rebound came, but no new-tool order is filed and the quarter used cash again.
In plain words
Our estimate of value
We forecast how much cash the business can earn over the next ten years and beyond, then ask what that stream is worth today to an investor who wants an 8% yearly return. We do it three times: a gloomy future, an expected one and a sunny one. We call a share Attractive only when its price is at least 20% below the expected estimate, and Unattractive when it is 20% above.